Hollis, NH, United States of America

James F Crittenden

This inventor holds 27 USPTO granted patents and 1 EPO patent, primarily in Cardiovascular Devices. Top assignees: C. R. Bard, Inc., Medtronic Vascular, Inc., Medtronic Ave, Inc.. Active years: 1981-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James F Crittenden. Retrieved from https://idiyas.com/inventor/james-f-crittenden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 92.6


Average Co-Inventor Count = 1.9

ph-index = 27

Forward Citations = 4,165(Granted Patents)


Location History:

  • Killingworth, CT (US) (1981)
  • Hollis, NH (US) (1987 - 2011)

Company Filing History:


Years Active: 1981-2011

Loading Chart...
Loading Chart...
Areas of Expertise:
Mitral Valve Regurgitation
Valve Annuloplasty
Intraluminal Filter
Endovascular Stent
Catheter Designation
Balloon Dilation
Guidewire Extension
Cerebral Angioplasty
Thermorecanalization
Steerable Guidewire
Pressure Control Apparatus
Detachable Luer Fitting
27 patents (USPTO):Explore Patents

Title: Innovations by James F. Crittenden in Cardiac Valve Technology

Introduction

James F. Crittenden, an accomplished inventor based in Hollis, NH, has made significant contributions to cardiac valve technology, evidenced by his impressive portfolio of 26 patents. His work focuses on innovative solutions for treating mitral valve regurgitation, showcasing his commitment to advancing medical technology.

Latest Patents

Among his latest patents is the "Coronary sinus approach for repair of mitral valve regurgitation." This invention features a specialized device designed to effectively treat cardiac valve regurgitation. The device consists of a tubular member with a lumen and incorporates both a locking mechanism and a compression device. The compression device can transform into a compression configuration through axial displacement and is secured in that configuration by the locking mechanism. The method involves positioning this compression device adjacent to a cardiac valve, applying axial displacement, and then locking it to exert a compressive force on the valve.

Another notable patent is his "Device, system, and method for aiding valve annuloplasty." This inventive device includes a reference ring that assists in non-optical visualization of the valve annulus. The reference ring can be transformed between a straight delivery format and a circular or helical deployment configuration. Its inflatables can expand temporarily on the inferior side of the valve annulus to create a ledge for optimal placement with an annuloplasty ring. This system also comprises a delivery catheter through which the reference ring can be accessed.

Career Highlights

James F. Crittenden has honed his skills and expertise working with leading medical technology companies, including C.R. Bard, Inc. and Medtronic Vascular, Inc. His dedication to developing groundbreaking technologies in cardiac care stems from his extensive experience in the industry, which has positioned him as a notable figure in the field.

Collaborations

Throughout his career, Crittenden has collaborated with esteemed professionals, including Richard A. Gambale and Bryan J. White. These partnerships have fostered innovative ideas and facilitated the development of advanced medical devices that significantly improve patient outcomes in cardiac procedures.

Conclusion

James F. Crittenden's innovative spirit and dedication to improving cardiac care continue to influence the field of medical device technology. His patents not only reflect his ingenuity but also underscore the vital importance of innovation in addressing complex medical challenges. Through his work, Crittenden remains a vital part of the evolution in treatment options for conditions such as mitral valve regurgitation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…